Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

Figure 4

Forest plot showing the effect of CCND1 amplification, cytoplasmic and nuclear cyclin D 1 expression. (a) Amplified against nonamplified breast cancers in the subgroups of treatment, nodal status and Ki67. (b) High cytoplasmic intensity against low or intermediate intensity. (c) Nuclear fraction of 1 to 100% against < 1% positive nuclei. Reference population for all subgroups was nonamplified patients (except for amplification status). HR, hazard ratio; neg, negative; pos, positive.

Back to article page